New York, NY– March 29, 2023 – CTERA, the leader in edge-to-cloud file services, today announced the promotion of Oded Nagel to chief executive officer (CEO), Michael Amselem to Chief Revenue Officer (CRO) and Saimon Michelson to Vice President of Alliances. All three executives are veterans of CTERA’s management team. Former CEO and co-founder Liran Eshel will serve… Read More »
Backed by Lakestar, Accel, and Cherry Ventures, the beta version of Rows’ app for Windows and MacOS is now live – iPad coming out next Rows recently made headlines launching a marketing campaign that saw two provocative billboards plastered outside Microsoft and Google HQs – signups have sprung up following the bold move Desktop apps’… Read More »
FRIDAY, May 14, 2021 — While millions of Americans rejoiced in the news on Thursday that the fully vaccinated can now skip masks in most indoor and outdoor settings, some worried that it will be nearly impossible to distinguish those who have gotten their shots from those who have not. “I think the challenge is… Read More »
Following reports of numerous home infestations, Utah health officials this week reminded residents of the dangers that bats can pose to one’s health. In Utah, bats are the primary carrier of the rabies virus, health officials said. Several recent investigations have involved bat infestations in family homes, according to Hannah Rettler, an epidemiologist with the Utah… Read More »
FDA Approves Enhertu (fam-trastuzumab deruxtecan-nxki) for HER2-Positive Unresectable or Metastatic Breast Cancer Following Two or More Prior Anti-HER2 Based Regimens Print this page 20 December 2019 — AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) today announced that the US Food and Drug Administration (FDA) has approved Enhertu® (fam-trastuzumab deruxtecan-nxki) for the treatment of adult… Read More »